{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:52:55Z","timestamp":1773827575111,"version":"3.50.1"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2593","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T23:21:59Z","timestamp":1408058519000},"page":"1873-1875","source":"Crossref","is-referenced-by-count":18,"title":["Grade 3 Lymphomatoid Granulomatosis in a Patient Receiving Methotrexate Therapy for Rheumatoid Arthritis"],"prefix":"10.2169","volume":"53","author":[{"given":"Hiroshi","family":"Oiwa","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keichiro","family":"Mihara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hiroshima University Hospital, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hiroshima University Hospital, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hiroshima University Hospital, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Lymphomatoid granulomatosis. In: World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues. Pittaluga S, Wilson WH, Jaffe ES, Eds. IARC Press, Lyon, 2008: 247-249."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J 20: 750-762, 2002.","DOI":"10.1183\/09031936.02.00404102"},{"key":"3","unstructured":"3. Shimada K, Matsui T, Kawakami M, et al. Methotrexate-related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis. Scand J Rheumatol 36: 64-67, 2007."},{"key":"4","unstructured":"4. Inaba M, Ushijim S, Hirata N, Saisyoji T, Kitaoka M, Yoshinaga T. Methotrexate-related lymphomatoid granulomatosis in a patient with rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi 49: 597-601, 2011 (in Japanese)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kobayashi S, Kikuchi Y, Sato K, et al. Reversible iatrogenic, MTX-associated EBV-driven lymphoproliferation with histopathological features of a lymphomatoid granulomatosis in a patient with rheumatoid arthritis. Ann Hematol 92: 1561-1564, 2013.","DOI":"10.1007\/s00277-013-1741-1"},{"key":"6","unstructured":"6. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909-3915, 2002."},{"key":"7","unstructured":"7. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kameda H, Okuyama A, Tamaru J, Itoyama S, Iizuka A, Takeuchi T. Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol 26: 1585-1589, 2007.","DOI":"10.1007\/s10067-006-0480-2"},{"key":"9","unstructured":"9. Schalk E, Krogel C, Scheinpflug K, Mohren M. Lymphomatoid granulomatosis in a patient with rheumatoid arthritis receiving methotrexate: successful treatment with the anti-CD20 antibody mabthera. Onkologie 32: 440-441, 2009."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/16\/53_53.2593\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:52:34Z","timestamp":1621446754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/16\/53_53.2593\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":9,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2593","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}